Literature DB >> 3882905

Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.

R L Childs, D J Hnatowich.   

Abstract

The covalent attachment of strong chelating groups such as DTPA to IgG antibodies may simplify the labeling of these proteins with 99mTc and may improve the stability of the label. Accordingly, we have investigated the labeling of DTPA-coupled antibodies by determining the effect of DTPA:tin molar ratio, pH, and DTPA concentration. We have determined that the optimum conditions are a molar ratio of 1:1.5, a pH of 4, a DTPA concentration as high as possible, and an antibody concentration as low as possible. Using these conditions, a DTPA-coupled antibody was labeled with 99mTc and its stability in 37 degrees C serum compared with that of the uncoupled antibody labeled in the identical fashion. High performance liquid chromatographic analysis of the incubates showed that the coupled antibody lost its label slowly compared to the uncoupled antibody. Both labeled antibodies were also administered to normal mice along with 111In-labeled coupled antibody as a further control. Biodistribution results obtained at 1 hr and 20 hr confirm the increased stability of the label in the case of the coupled antibody and provide evidence for redistribution of the 99mTc following catabolism at sites of localization. To obtain the above results, however, it was necessary to attach an average of two to five DTPA groups per antibody molecule. Furthermore, it was not possible to reduce to negligible levels nonspecific binding of 99mTc to the antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882905

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment:a radioimmunoconjugate for hepatocellular carcinoma imaging.

Authors:  Hui-Jie Bian; Zhi-Nan Chen; Jing-Lan Deng
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 2.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

3.  Binding of ReO4(-) with an engineered MoO4(2-)-binding protein: towards a new approach in radiopharmaceutical applications.

Authors:  Baikuntha P Aryal; Pedro Brugarolas; Chuan He
Journal:  J Biol Inorg Chem       Date:  2011-08-23       Impact factor: 3.358

4.  Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi.

Authors:  D J Hnatowich; F Virzi; P W Doherty; J Wilson; J Rosa; J E Ansell
Journal:  Eur J Nucl Med       Date:  1987

5.  A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.

Authors:  S M Andrew; A C Perkins; M V Pimm; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1988

6.  Radioimmunoimaging of tumors with radioactive antibody against a glycoprotein (GP68) found in developing mouse brain.

Authors:  S Kojima; A Awaya; M Ishido; Y Koyama; A Kubodera; Y Hashimoto; H Fukui; H Muramatsu; T Muramatsu
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody.

Authors:  Q Chen; S Yuan
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.

Authors:  J Xiang; J Koropatnick; Y Qi; X Luo; T Moyana; K Li; Y Chen
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Authors:  A R Fritzberg; P G Abrams; P L Beaumier; S Kasina; A C Morgan; T N Rao; J M Reno; J A Sanderson; A Srinivasan; D S Wilbur
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts.

Authors:  S M Andrew; M V Pimm; A C Perkins; R W Baldwin
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.